Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of subscription and Board changes

17 Feb 2016 16:34

RNS Number : 3828P
Frontier Resources International
17 February 2016
 

For immediate release

 

17 February 2016

 

Frontier Resources International Plc

("Frontier" or the "Company")

Completion of subscription

 and Board changes

 

The Board of Frontier (AIM Ticker: FRI) announces that the direct subscription of 4,750,000,000 new ordinary shares of 0.01p each to raise £1,425,000 before expenses (the "Subscription") completed today and the new shares have been admitted to trading on AIM.

 

In addition, as previously announced, Adam Reynolds has today been appointed to the Board as Chairman of the Company and Jack Keyes and John O'Donovan have ceased to be directors of Frontier.

 

Total voting rights

Following the issue of the Subscription shares, the Company's issued share capital consists of 5,111,999,056 Ordinary Shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Enquiries:

Frontier Resources International Plc

Adam Reynolds, Chairman

 

Tel: +44 (0) 7785 908158

Beaumont Cornish (Nomad)

Michael Cornish

Emily Staples

 

Tel: +44 (0)20 7628 3396

Beaufort Securities Limited (Broker)

Jon Belliss

 

 

Tel: +44 (0)20 7382 8300

A copy of this announcement is available from the Company's website www.friplc.com

 

APPENDIX

 

The following information is disclosed pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies:

 

Adam Reynolds, aged 53, has held the following directorships and / or partnerships in the past 5 years:

 

Current:

Past:

Ocutec Eyecare Limited

Bcomp 415 Limited

Premaitha Health plc

Biolustre UK Ltd

Optibiotix Health plc

Wallgate Group plc

Autoclenz Group Limited

Wilton International Marketing Limited

Hubco Investments plc

Alan Bailey (Studios) Limited

Reyco Limited

Hansard Corporate Limited

Medavinci Gold Limited

Chalton Consulting Limited

Emotion Fitness Limited

React Group plc

Orogen Gold plc

Hub Capital Partners Limited

Boldwood Limited

Velvet Consultancy Ltd

EKF Diagnostics Holdings plc

Porta Communications Plc

Autoclenz Holdings Limited

Diablo Consulting Limited

New World Oil & Gas Limited

Bcomp 429 Limited

RNR Holdings Limited

Venn Life Sciences Holdings plc

 

Bcomp 416 Limited

 

Autoclenz Group Limited

 

Wallgate Group plc

Mr Reynolds was appointed as a director of Wallgate Group plc on 3 July 2008 and resigned on 28 November 2008. Wallgate Group plc was put into administration on 12 December 2008 and became subject to creditors' voluntary liquidation on 15 December 2009. The liquidator's statement of receipts of payments to 25 February 2011 showed a creditor shortfall of £419,782.12. Wallgate Group plc was subsequently dissolved on 1 June 2011.

 

Greenhills plc

Mr Reynolds was appointed as a director of Greenhills plc on 22 December 1994. He resigned on 24 January 1996. Greenhills plc was put into receivership on 8 August 1996, and an order to wind the company up was made on 19 February 1997. The receiver's abstract of receipts and payments to 6 July 1998 showed a creditor shortfall of £216,877.32. Greenhills plc was subsequently dissolved on 2 January 2001.

 

Wilton International Marketing Limited

Mr Reynolds was appointed as a director of Wilton International Marketing Limited on 10 June 2005. Wilton International Marketing Limited was put into voluntary liquidation on 14 October 2013 and was subsequently dissolved on 1 August 2014 with no shortfall to creditors.

 

There is no further information to be disclosed in relation to Mr Reynolds pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKODNABKDBBD
Date   Source Headline
27th Sep 20187:00 amRNSInterim Results
21st Sep 20189:47 amRNSHolding(s) in Company
28th Aug 20187:00 amRNSHolding(s) in Company
13th Aug 201812:55 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHolding(s) in Company
9th Aug 201812:15 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSOversubscribed placing raises £2,000,000
17th Jul 20187:00 amRNSBoard Changes
14th Jun 201810:22 amRNSResult of AGM
22nd May 20185:13 pmRNSNotice of AGM
1st May 20187:00 amRNSFinal Results
26th Apr 201810:00 amRNSLogistics deal with major Chinese player SinoPharm
9th Apr 20188:25 amRNSConcepta manufacturing site achieves certification
29th Mar 20187:00 amRNSConcepta pre-launch myLotus in the UK
8th Mar 20187:00 amRNSmyLotus obtains approval to commence trial in UK
20th Feb 20187:00 amRNSLaunch of myLotus app in China
16th Feb 20187:00 amRNSTwo Senior Appointments and Grant of Options
15th Feb 20187:00 amRNSConcepta signs marketing contract in China
2nd Feb 20184:17 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSResults of Chinese hospital evaluations of myLotus
2nd Jan 201812:52 pmRNSChange of Broker
22nd Dec 201711:30 amRNSTrading update
14th Dec 20177:00 amRNSAssembly held in Shanghai to showcase myLotus
30th Nov 20173:05 pmRNSDirector/PDMR Shareholding
29th Nov 20179:02 amRNSHolding(s) in Company
13th Nov 20177:02 amRNSAppointment of Joint Corporate Broker
13th Nov 20177:01 amRNSOversubscribed equity fundraising of £2,000,000
13th Nov 20177:00 amRNSSales Order
6th Nov 201712:53 pmRNSTrading and Order Update
16th Oct 20177:00 amRNSmyLotus Fertility Product - China Update
19th Sep 20177:00 amRNSInterim Results
23rd Aug 201712:00 pmRNSCorporate Update
26th Jun 20177:00 amRNSDirector Shareholding
14th Jun 201712:00 pmRNSResult of AGM
13th Jun 20177:00 amRNSFirst Sales Order China and Trading Update
24th May 20174:58 pmRNSNotice of AGM
10th May 20177:00 amRNSFirst distributor agreement in China
26th Apr 20177:00 amRNSFinal Results
29th Mar 201710:00 amRNSUK Investor Show 2017
28th Mar 20177:00 amRNSDirectorate Changes
14th Feb 20171:45 pmRNSChange of Registered Office
7th Feb 20177:00 amRNSConcepta signs agreement with Selective Antibodies
9th Jan 20177:00 amRNSConcepta achieves ISO13485 accreditation
8th Dec 20167:00 amRNSAppointment China Country Manager
8th Nov 20167:09 amRNSNew manufacturing facility in Doncaster
10th Oct 20163:53 pmRNSIssue of Equity
26th Sep 20167:00 amRNSChinese Manufacturing Agreement Signed
21st Sep 20167:00 amRNSNew Laboratory Opening
18th Aug 20167:00 amRNSInterim Results
27th Jul 20164:11 pmRNSTR-1: Notification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.